               SEQUENCE LISTING

<110> INSERM

<120> Soluble HLA-I/peptide monomers and applications as therapeutic treatments in cancer 

<130> BEP140315 EP 

<160> 38

<170> BiSSAP 1.3

<210> 1
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 1
Glu Ala Asp Pro Thr Gly His Ser Tyr 
1               5                   

<210> 2
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 2
Glu Val Asp Pro Ile Gly His Leu Tyr 
1               5                   

<210> 3
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 3
Ser Ser Asp Tyr Val Ile Pro Ile Gly Thr Tyr 
1               5                   10      

<210> 4
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 4
Glu Ala Ala Gly Ile Gly Ile Leu Thr Val 
1               5                   10  

<210> 5
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 5
Glu Ala Ala Gly Ile Gly Ile Leu Thr Tyr 
1               5                   10  

<210> 6
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 6
Glu Pro Ala Gly Ile Gly Ile Leu Thr Tyr 
1               5                   10  

<210> 7
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 7
Val Pro Leu Asp Cys Val Leu Tyr Arg Tyr 
1               5                   10  

<210> 8
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 8
Met Pro Phe Ala Thr Pro Met Glu Ala 
1               5                   

<210> 9
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 9
Glu Val Asp Pro Ile Gly His Leu Tyr 
1               5                   

<210> 10
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 10
Ala Ala Gly Ile Gly Ile Leu Thr Val 
1               5                   

<210> 11
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 11
Glu Leu Ala Gly Ile Gly Ile Leu Thr Val 
1               5                   10  

<210> 12
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 12
Thr Leu Asn Asp Glu Cys Trp Pro Ala 
1               5                   

<210> 13
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 13
Val Leu Pro Asp Val Phe Ile Arg Cys 
1               5                   

<210> 14
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 14
Ser Leu Leu Met Trp Ile Thr Gln Cys 
1               5                   

<210> 15
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 15
Lys Ile Phe Gly Ser Leu Ala Phe Leu 
1               5                   

<210> 16
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 16
Ile Ile Ser Ala Val Val Gly Ile Leu 
1               5                   

<210> 17
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 17
Tyr Leu Ser Gly Ala Asn Leu Asn Leu 
1               5                   

<210> 18
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 18
Phe Leu Thr Pro Lys Lys Leu Gln Cys Val 
1               5                   10  

<210> 19
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 19
Trp Met Met Trp Tyr Trp Gly Pro Ser Leu Tyr 
1               5                   10      

<210> 20
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 20
Asp Leu Leu Asp Thr Ala Ser Ala Leu Tyr 
1               5                   10  

<210> 21
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 21
Ile Pro Ile Pro Ser Ser Trp Ala Phe 
1               5                   

<210> 22
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 22
Phe Pro His Cys Leu Ala Phe Ser Tyr Met 
1               5                   10  

<210> 23
<211> 8
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 23
Arg Ala Lys Phe Lys Gln Leu Leu 
1               5               

<210> 24
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 24
Phe Leu Arg Gly Arg Ala Tyr Gly Leu 
1               5                   

<210> 25
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 25
Val Leu Glu Glu Thr Ser Val Met Leu 
1               5                   

<210> 26
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 26
Asn Leu Val Pro Met Val Ala Thr Val 
1               5                   

<210> 27
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 27
Gly Leu Cys Thr Leu Val Ala Met Leu 
1               5                   

<210> 28
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 28
Cys Leu Gly Gly Leu Leu Thr Met Val 
1               5                   

<210> 29
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 29
Asp Leu Met Gly Tyr Ile Pro Leu Val 
1               5                   

<210> 30
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 30
Lys Leu Val Ala Leu Gly Ile Asn Ala Val 
1               5                   10  

<210> 31
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 31
Ala Leu Tyr Asp Val Val Thr Lys Leu 
1               5                   

<210> 32
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 32
Phe Leu Leu Thr Arg Ile Leu Thr Ile 
1               5                   

<210> 33
<211> 10
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 33
Phe Leu Pro Ser Asp Phe Phe Pro Ser Val 
1               5                   10  

<210> 34
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 34
Tyr Met Asp Asp Val Val Leu Gly Val 
1               5                   

<210> 35
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 35
His Leu Ser Leu Arg Gly Leu Pro Val 
1               5                   

<210> 36
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 36
Val Leu His Lys Arg Thr Leu Gly Leu 
1               5                   

<210> 37
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 37
Cys Leu Phe Lys Asp Trp Glu Glu Leu 
1               5                   

<210> 38
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> peptide

<400> 38
Gln Met Arg Pro Val Ser Arg Val Leu 
1               5                   

